Alastair M. Buchan, Dsc FRCP - Publications

Affiliations: 
Nuffield Department of Clinical Medicine University of Oxford, Oxford, United Kingdom 
Area:
Stroke

235 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Mergenthaler P, Balami JS, Neuhaus AA, Mottahedin A, Albers GW, Rothwell PM, Saver JL, Young ME, Buchan AM. Stroke in the Time of Circadian Medicine. Circulation Research. 134: 770-790. PMID 38484031 DOI: 10.1161/CIRCRESAHA.124.323508  0.419
2023 Mandeville ET, Buchan AM, Tiedt S. Not open and shut: Complex and prolonged blood-brain barrier responses after stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X231216153. PMID 38000041 DOI: 10.1177/0271678X231216153  0.343
2023 Schneider AM, Neuhaus AA, Hadley G, Balami JS, Harston GW, DeLuca GC, Buchan AM. Posterior circulation ischaemic stroke diagnosis and management. Clinical Medicine (London, England). 23: 219-227. PMID 37236792 DOI: 10.7861/clinmed.2022-0499  0.333
2023 Schneider AM, Neuhaus AA, Hadley G, Balami JS, Harston GW, DeLuca GC, Buchan AM. Posterior circulation ischaemic stroke diagnosis and management. Clinical Medicine (London, England). 23: 219-227. PMID 37236792 DOI: 10.7861/clinmed.2022-0499  0.333
2022 Schneider AM, Regenhardt RW, Dmytriw AA, Patel AB, Hirsch JA, Buchan AM. Cerebroprotection in the endovascular era: an update. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 36600581 DOI: 10.1136/jnnp-2022-330379  0.353
2022 Walther J, Kirsch EM, Hellwig L, Schmerbeck SS, Holloway PM, Buchan AM, Mergenthaler P. Reinventing the Penumbra - the Emerging Clockwork of a Multi-modal Mechanistic Paradigm. Translational Stroke Research. PMID 36219377 DOI: 10.1007/s12975-022-01090-9  0.382
2022 Neuhaus AA, Buchan AM. Expanding horizons in the endovascular treatment of stroke: larger cores and adjunct thrombolytics. Cardiovascular Research. 118: e91-e95. PMID 36165895 DOI: 10.1093/cvr/cvac145  0.389
2022 Tiedt S, Buchan AM, Dichgans M, Lizasoain I, Moro MA, Lo EH. The neurovascular unit and systemic biology in stroke - implications for translation and treatment. Nature Reviews. Neurology. 18: 597-612. PMID 36085420 DOI: 10.1038/s41582-022-00703-z  0.405
2021 Buchan AM, Pelz DM. Neuroprotection in Acute Ischemic Stroke: A Brief Review. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 49: 741-745. PMID 34526172 DOI: 10.1017/cjn.2021.223  0.429
2021 Rothwell PM, Buchan AM. A new thrombolytic drug for acute ischaemic stroke. The Lancet. Neurology. 20: 687-689. PMID 34418384 DOI: 10.1016/S1474-4422(21)00256-8  0.354
2021 Lo EH, Albers GW, Dichgans M, Donnan G, Esposito E, Foster R, Howells DW, Huang YG, Ji X, Klerman EB, Lee S, Li W, Liebeskind DS, Lizasoain I, Mandeville ET, ... ... Buchan AM, et al. Circadian Biology and Stroke. Stroke. STROKEAHA120031742. PMID 33940951 DOI: 10.1161/STROKEAHA.120.031742  0.383
2020 Sutherland BA, Hadley G, Alexopoulou Z, Lodge TA, Neuhaus AA, Couch Y, Kalajian N, Morten KJ, Buchan AM. Growth Differentiation Factor-11 Causes Neurotoxicity During Ischemia . Frontiers in Neurology. 11: 1023. PMID 33013673 DOI: 10.3389/Fneur.2020.01023  0.337
2020 Beard DJ, Li Z, Schneider AM, Couch Y, Cipolla MJ, Buchan AM. Rapamycin Induces an eNOS (Endothelial Nitric Oxide Synthase) Dependent Increase in Brain Collateral Perfusion in Wistar and Spontaneously Hypertensive Rats. Stroke. STROKEAHA120029781. PMID 32772681 DOI: 10.1161/Strokeaha.120.029781  0.368
2020 Popkirov S, Stone J, Buchan AM. Functional Neurological Disorder: A Common and Treatable Stroke Mimic. Stroke. STROKEAHA120029076. PMID 32295508 DOI: 10.1161/Strokeaha.120.029076  0.453
2019 Hadley G, Beard DJ, Alexopoulou Z, Sutherland BA, Buchan AM. Investigation of the novel mTOR inhibitor AZD2014 in neuronal ischemia. Neuroscience Letters. PMID 31100427 DOI: 10.1016/J.Neulet.2019.05.023  0.398
2018 Harston G, Grunwald I, Buchan A. Letter by Harston et al Regarding Article, "Alberta Stroke Program Early CT Score Versus Computed Tomographic Perfusion to Predict Functional Outcome After Successful Reperfusion in Acute Ischemic Stroke". Stroke. STROKEAHA118023749. PMID 30580743 DOI: 10.1161/Strokeaha.118.023749  0.474
2018 Beard DJ, Hadley G, Thurley N, Howells DW, Sutherland BA, Buchan AM. The effect of rapamycin treatment on cerebral ischemia: A systematic review and meta-analysis of animal model studies. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493018816503. PMID 30489210 DOI: 10.1177/1747493018816503  0.418
2018 Hadley G, Beard DJ, Couch Y, Neuhaus AA, Adriaanse BA, DeLuca GC, Sutherland BA, Buchan AM. Rapamycin in ischemic stroke: Old drug, new tricks? Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18807309. PMID 30334673 DOI: 10.1177/0271678X18807309  0.461
2018 Balami J, Coughlan D, McMeekin P, White P, Flynn D, Roffe C, Wiggam I, Flynn P, Chembala J, Natarajan I, Dixit A, Hunter A, Foddy L, Hopkins E, Lumley H, ... ... Buchan A, et al. Case costing of mechanical thrombectomy for acute ischaemic stroke in routine clinical setting:: cost differences between mothership vs drip and ship International Journal of Stroke. 13: 45-46. DOI: 10.1177/1747493018801108  0.393
2017 Balami JS, White PM, McMeekin PJ, Ford GA, Buchan AM. Complications of endovascular treatment for acute ischemic stroke: Prevention and management. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493017743051. PMID 29171362 DOI: 10.1177/1747493017743051  0.463
2017 Couch Y, Akbar N, Roodselaar J, Evans MC, Gardiner C, Sargent I, Romero IA, Bristow A, Buchan AM, Haughey N, Anthony DC. Circulating endothelial cell-derived extracellular vesicles mediate the acute phase response and sickness behaviour associated with CNS inflammation. Scientific Reports. 7: 9574. PMID 28851955 DOI: 10.1038/S41598-017-09710-3  0.491
2017 Neuhaus AA, Couch Y, Hadley G, Buchan AM. Neuroprotection in stroke: the importance of collaboration and reproducibility. Brain : a Journal of Neurology. PMID 28641383 DOI: 10.1093/Brain/Awx126  0.532
2017 Couch Y, Akbar N, Davis S, Fischer R, Dickens AM, Neuhaus AA, Burgess AI, Rothwell PM, Buchan AM. Inflammatory Stroke Extracellular Vesicles Induce Macrophage Activation. Stroke. PMID 28536169 DOI: 10.1161/Strokeaha.117.017236  0.467
2017 Howarth C, Sutherland BA, Choi HB, Martin C, Lind BL, Khennouf L, LeDue JM, Pakan JM, Ko RW, Ellis-Davies GC, Lauritzen MJ, Sibson NR, Buchan AM, MacVicar BA. A critical role for astrocytes in hypercapnic vasodilation in brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28137973 DOI: 10.1523/Jneurosci.0005-16.2016  0.321
2017 Kongbunkiat K, Wilson D, Kasemsap N, Tiamkao S, Jichi F, Palumbo V, Hill MD, Buchan AM, Jung S, Mattle HP, Henninger N, Werring DJ. Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis. Neurology. PMID 28130468 DOI: 10.1212/Wnl.0000000000003605  0.44
2016 Nagel S, Sinha D, Day D, Reith W, Chapot R, Papanagiotou P, Warburton EA, Guyler P, Tysoe S, Fassbender K, Walter S, Essig M, Heidenrich J, Konstas AA, Harrison M, ... ... Buchan AM, et al. e-ASPECTS software is non-inferior to neuroradiologists in applying the ASPECT score to computed tomography scans of acute ischemic stroke patients. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 27899743 DOI: 10.1177/1747493016681020  0.454
2016 Sutherland BA, Fordsmann JC, Martin C, Neuhaus AA, Witgen BM, Piilgaard H, Lønstrup M, Couch Y, Sibson NR, Lauritzen M, Buchan AM. Multi-modal assessment of neurovascular coupling during cerebral ischaemia and reperfusion using remote middle cerebral artery occlusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27629101 DOI: 10.1177/0271678X16669512  0.36
2016 Neuhaus AA, Couch Y, Sutherland BA, Buchan AM. Novel method to study pericyte contractility and responses to ischaemia in vitro using electrical impedance. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27418036 DOI: 10.1177/0271678X16659495  0.356
2016 Arba F, Palumbo V, Boulanger JM, Pracucci G, Inzitari D, Buchan AM, Hill MD. Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis. International Journal of Stroke : Official Journal of the International Stroke Society. 11: 62-7. PMID 26763021 DOI: 10.1177/1747493015607517  0.511
2016 Arba F, Palumbo V, Boulanger JM, Pracucci G, Inzitari D, Buchan AM, Hill MD. Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis International Journal of Stroke. 11: 62-67. DOI: 10.1177/1747493015607517  0.406
2015 Sutherland BA, Neuhaus AA, Couch Y, Balami JS, DeLuca GC, Hadley G, Harris SL, Grey AN, Buchan AM. The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26661175 DOI: 10.1177/0271678X15606722  0.448
2015 Buchan AM, Karbalai HG, Sutherland BA. The future of stroke therapy must not be mired by past arguments The Lancet. 386: 654. PMID 26334159 DOI: 10.1016/S0140-6736(15)61503-3  0.473
2015 Balami JS, Sutherland BA, Edmunds LD, Grunwald IQ, Neuhaus AA, Hadley G, Karbalai H, Metcalf KA, DeLuca GC, Buchan AM. A systematic review and meta-analysis of randomized controlled trials of endovascular thrombectomy compared with best medical treatment for acute ischemic stroke. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 26310289 DOI: 10.1111/Ijs.12618  0.485
2015 Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. Reply: Intravenous thrombolysis for ischaemic strokes: A call for reappraisal Brain. 138: e342. PMID 25281865 DOI: 10.1093/Brain/Awu283  0.376
2015 Redzic ZB, Rabie T, Sutherland BA, Buchan AM. Differential effects of paracrine factors on the survival of cells of the neurovascular unit during oxygen glucose deprivation International Journal of Stroke. 10: 407-414. DOI: 10.1111/Ijs.12197  0.302
2014 Chen RL, Ogunshola OO, Yeoh KK, Jani A, Papadakis M, Nagel S, Schofield CJ, Buchan AM. HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice. Journal of Neurochemistry. PMID 24974727 DOI: 10.1111/Jnc.12804  0.376
2014 Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. Reply: Thrombolysis in acute ischaemic stroke Brain. 137: e282. PMID 24727568 DOI: 10.1093/Brain/Awu066  0.441
2014 Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O'Farrell FM, Buchan AM, Lauritzen M, Attwell D. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 508: 55-60. PMID 24670647 DOI: 10.1038/Nature13165  0.318
2014 Neuhaus AA, Rabie T, Sutherland BA, Papadakis M, Hadley G, Cai R, Buchan AM. Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke Jama Neurology. 71: 634-639. PMID 24590416 DOI: 10.1001/Jamaneurol.2013.6299  0.523
2014 Sutherland BA, Rabie T, Buchan AM. Laser doppler flowmetry to measure changes in cerebral blood flow Methods in Molecular Biology. 1135: 237-248. PMID 24510869 DOI: 10.1007/978-1-4939-0320-7_20  0.35
2014 Young CC, Al-Dalahmah O, Lewis NJ, Brooks KJ, Jenkins MM, Poirier F, Buchan AM, Szele FG. Blocked angiogenesis in Galectin-3 null mice does not alter cellular and behavioral recovery after middle cerebral artery occlusion stroke. Neurobiology of Disease. 63: 155-64. PMID 24269916 DOI: 10.1016/J.Nbd.2013.11.003  0.802
2013 Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. The exact science of stroke thrombolysis and the quiet art of patient selection Brain. 136: 3528-3553. PMID 24038074 DOI: 10.1093/Brain/Awt201  0.531
2013 Sutherland BA, Buchan AM. Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat Journal of Cerebral Blood Flow and Metabolism. 33: E1-E7. PMID 23963368 DOI: 10.1038/Jcbfm.2013.148  0.472
2013 Hadley G, De Luca GC, Papadakis M, Buchan AM. Endogenous neuroprotection: Hamartin modulates an austere approach to staying alive in a recession International Journal of Stroke. 8: 449-450. PMID 23879750 DOI: 10.1111/Ijs.12130  0.398
2013 Balami JS, Chen RL, Buchan AM. Stroke syndromes and clinical management. Qjm : Monthly Journal of the Association of Physicians. 106: 607-15. PMID 23483140 DOI: 10.1093/qjmed/hct057  0.371
2013 Papadakis M, Hadley G, Xilouri M, Hoyte LC, Nagel S, McMenamin MM, Tsaknakis G, Watt SM, Drakesmith CW, Chen R, Wood MJ, Zhao Z, Kessler B, Vekrellis K, Buchan AM. Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nature Medicine. 19: 351-7. PMID 23435171 DOI: 10.1038/Nm.3097  0.414
2013 Balami JS, Sutherland BA, Buchan AM. Complications associated with recombinant tissue plasminogen activator therapy for acute Ischaemic stroke Cns and Neurological Disorders - Drug Targets. 12: 155-169. PMID 23394532 DOI: 10.2174/18715273112119990050  0.463
2013 Balami JS, Chen R, Sutherland BA, Buchan AM. Thrombolytic agents for acute ischaemic stroke treatment: The past, present and future Cns and Neurological Disorders - Drug Targets. 12: 145-154. PMID 23394531 DOI: 10.2174/18715273113129990057  0.482
2013 Hill MD, Kenney C, Dzialowski I, Boulanger JM, Demchuk AM, Barber PA, Watson TW, Weir NU, Buchan AM. Tissue Window in Stroke Thrombolysis study (TWIST): a safety study. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 40: 17-20. PMID 23250122 DOI: 10.1017/S0317167100012890  0.528
2013 Young CC, van der Harg JM, Lewis NJ, Brooks KJ, Buchan AM, Szele FG. Ependymal ciliary dysfunction and reactive astrocytosis in a reorganized subventricular zone after stroke. Cerebral Cortex (New York, N.Y. : 1991). 23: 647-59. PMID 22414771 DOI: 10.1093/Cercor/Bhs049  0.808
2013 Balami JS, Chen RL, Buchan AM. Stroke syndromes and clinical management Qjm. 106: 607-615. DOI: 10.1093/Qjmed/Hct057  0.472
2012 Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Neuroprotection for stroke: current status and future perspectives. International Journal of Molecular Sciences. 13: 11753-11772. PMID 23109881 DOI: 10.3390/ijms130911753  0.429
2012 Nagel S, Hadley G, Pfleger K, Grond-Ginsbach C, Buchan AM, Wagner S, Papadakis M. Suppression of the inflammatory response by diphenyleneiodonium after transient focal cerebral ischemia Journal of Neurochemistry. 123: 98-107. PMID 23050647 DOI: 10.1111/J.1471-4159.2012.07948.X  0.319
2012 Chen RL, Nagel S, Papadakis M, Bishop T, Pollard P, Ratcliffe PJ, Pugh CW, Buchan AM. Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice Journal of Physiology. 590: 4079-4091. PMID 22615432 DOI: 10.1113/Jphysiol.2012.232884  0.345
2012 Rothwell PM, Buchan AM. Mobile acute stroke units: bringing the hospital to the patient. The Lancet. Neurology. 11: 382-3. PMID 22497930 DOI: 10.1016/S1474-4422(12)70069-8  0.443
2012 Dzialowski I, Puetz V, Buchan AM, Demchuk AM, Hill MD. Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients? Stroke. 43: 1567-1571. PMID 22496336 DOI: 10.1161/Strokeaha.112.651737  0.429
2012 Sutherland BA, Minnerup J, Balami JS, Arba F, Buchan AM, Kleinschnitz C. Neuroprotection for ischaemic stroke: Translation from the bench to the bedside International Journal of Stroke. 7: 407-418. PMID 22394615 DOI: 10.1111/J.1747-4949.2012.00770.X  0.532
2012 Nagel S, Papadakis M, Pfleger K, Grond-Ginsbach C, Buchan AM, Wagner S. Microarray analysis of the global gene expression profile following hypothermia and transient focal cerebral ischemia Neuroscience. 208: 109-122. PMID 22366221 DOI: 10.1016/J.Neuroscience.2012.01.048  0.313
2012 Balami JS, Buchan AM. Complications of intracerebral haemorrhage The Lancet Neurology. 11: 101-118. PMID 22172625 DOI: 10.1016/S1474-4422(11)70264-2  0.451
2012 Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Neuroprotection for stroke: Current status and future perspectives International Journal of Molecular Sciences. 13: 11753-11772. DOI: 10.3390/Ijms130911753  0.521
2012 Montagu A, Reckless IP, Buchan AM. Stroke: Management and prevention Medicine (United Kingdom). 40: 490-499. DOI: 10.1016/J.Mpmed.2016.06.003  0.499
2011 Sutherland BA, Papadakis M, Chen RL, Buchan AM. Cerebral blood flow alteration in neuroprotection following cerebral ischaemia. The Journal of Physiology. 589: 4105-14. PMID 21708904 DOI: 10.1113/jphysiol.2011.209601  0.308
2011 Balami JS, Chen RL, Grunwald IQ, Buchan AM. Neurological complications of acute ischaemic stroke The Lancet Neurology. 10: 357-371. PMID 21247806 DOI: 10.1016/S1474-4422(10)70313-6  0.439
2011 Grunwald IQ, Wakhloo AK, Walter S, Molyneux AJ, Byrne JV, Nagel S, Kühn AL, Papadakis M, Fassbender K, Balami JS, Roffi M, Sievert H, Buchan A. Endovascular stroke treatment today. Ajnr. American Journal of Neuroradiology. 32: 238-43. PMID 21233233 DOI: 10.3174/Ajnr.A2346  0.476
2011 Shobha N, Buchan AM, Hill MD. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset - Evidence from the Canadian alteplase for stroke effectiveness study (CASES) registry Cerebrovascular Diseases. 31: 223-228. PMID 21178345 DOI: 10.1159/000321893  0.44
2011 Young CC, Brooks KJ, Buchan AM, Szele FG. Cellular and molecular determinants of stroke-induced changes in subventricular zone cell migration. Antioxidants & Redox Signaling. 14: 1877-88. PMID 20673127 DOI: 10.1089/Ars.2010.3435  0.805
2011 Nagel S, Papadakis M, Chen R, Hoyte LC, Brooks KJ, Gallichan D, Sibson NR, Pugh C, Buchan AM. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 132-43. PMID 20407463 DOI: 10.1038/Jcbfm.2010.60  0.353
2011 Sutherland BA, Papadakis M, Chen RL, Buchan AM. Cerebral blood flow alteration in neuroprotection following cerebral ischaemia Journal of Physiology. 589: 4105-4114. DOI: 10.1113/Jphysiol.2011.209601  0.42
2010 Harston GWJ, Sutherland BA, Kennedy J, Buchan AM. The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: A review of rtPA neurotoxicity Journal of Cerebral Blood Flow and Metabolism. 30: 1804-1816. PMID 20736961 DOI: 10.1038/Jcbfm.2010.149  0.478
2010 Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, et al. Stroke: working toward a prioritized world agenda. International Journal of Stroke : Official Journal of the International Stroke Society. 5: 238-56. PMID 20636706 DOI: 10.1111/j.1747-4949.2010.00442.x  0.429
2010 Mateen FJ, Buchan AM, Hill MD. Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians Stroke. 41: 1833-1835. PMID 20576948 DOI: 10.1161/Strokeaha.110.586438  0.499
2010 Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, et al. Stroke: working toward a prioritized world agenda. Cerebrovascular Diseases (Basel, Switzerland). 30: 127-47. PMID 20516682 DOI: 10.1159/000315099  0.521
2010 Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, et al. Stroke: working toward a prioritized world agenda. Stroke; a Journal of Cerebral Circulation. 41: 1084-99. PMID 20498453 DOI: 10.1161/Strokeaha.110.586156  0.521
2010 Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM. Ischemic stroke in the elderly: An overview of evidence Nature Reviews Neurology. 6: 256-265. PMID 20368741 DOI: 10.1038/Nrneurol.2010.36  0.534
2010 Geraghty OC, Kennedy J, Chandratheva A, Marquardt L, Buchan AM, Rothwell PM. Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naïve patients in the acute phase after TIA or minor ischaemic stroke. Cerebrovascular Diseases (Basel, Switzerland). 29: 460-7. PMID 20299785 DOI: 10.1159/000297961  0.369
2010 Hoyte LC, Brooks KJ, Nagel S, Akhtar A, Chen R, Mardiguian S, McAteer MA, Anthony DC, Choudhury RP, Buchan AM, Sibson NR. Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1178-87. PMID 20087364 DOI: 10.1038/Jcbfm.2009.287  0.563
2010 Hoyte LC, Buchan AM. Animal Models of Stroke Encyclopedia of Neuroscience. 465-472. DOI: 10.1016/B978-008045046-9.00531-3  0.393
2009 Wu CM, Manns BJ, Hill MD, Ghali WA, Donaldson C, Buchan AM. Rapid evaluation after high-risk TIA is associated with lower stroke risk Canadian Journal of Neurological Sciences. 36: 450-455. PMID 19650355 DOI: 10.1017/S0317167100007770  0.371
2009 Steffenhagen N, Hill MD, Poppe AY, Buchan AM, Coutts SB. Should you thrombolyze all or any stroke patients with baseline national institutes of health stroke scale scores ≤5? Cerebrovascular Diseases. 28: 201-202. PMID 19571531 DOI: 10.1159/000226579  0.486
2009 Bath PM, Gray LJ, Bath AJ, Buchan A, Miyata T, Green AR. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. British Journal of Pharmacology. 157: 1157-71. PMID 19422398 DOI: 10.1111/J.1476-5381.2009.00196.X  0.472
2009 Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman RJ, Minematsu K, Donnan GA, Howells DW. Reprint: Good laboratory practice: preventing introduction of bias at the bench. International Journal of Stroke : Official Journal of the International Stroke Society. 4: 3-5. PMID 19236488 DOI: 10.1111/J.1747-4949.2009.00241.X  0.326
2009 Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis Diabetes Care. 32: 617-622. PMID 19131465 DOI: 10.2337/Dc08-1754  0.431
2009 Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, Buchan A, van der Worp HB, Traystman RJ, Minematsu K, Donnan GA, Howells DW. Reprint: Good laboratory practice: preventing introduction of bias at the bench. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 221-3. PMID 18797473 DOI: 10.1038/Jcbfm.2008.101  0.326
2009 Papadakis M, Buchan A. Approaches to neuroprotective and reperfusion injury therapy Handbook of Clinical Neurology / Edited by P.J. Vinken and G.W. Bruyn. 94: 1205-1223. PMID 18793896 DOI: 10.1016/S0072-9752(08)94059-8  0.417
2009 Chen LK, McClaran J, Buchan AM. Impact of acute stroke unit on hospital length of stay Archives of Gerontology and Geriatrics. 49: e12-e15. PMID 18789547 DOI: 10.1016/J.Archger.2008.07.008  0.459
2009 Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman R, Minematsu K, Donnan GA, Howells DW. Good laboratory practice: preventing introduction of bias at the bench. Stroke; a Journal of Cerebral Circulation. 40: e50-2. PMID 18703798 DOI: 10.1161/Strokeaha.108.525386  0.324
2008 Coutts SB, Eliasziw M, Hill MD, Scott JN, Subramaniam S, Buchan AM, Demchuk AM, Fischer K, Kenney C, Ryckborst K, McClelland M, Cole-Haskayne A, Newcommon N, Werdal K, Krol A, et al. An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke International Journal of Stroke. 3: 3-10. PMID 18705908 DOI: 10.1111/J.1747-4949.2008.00182.X  0.493
2008 Reckless I, Nagel S, Buchan A. Setting up an acute stroke service International Journal of Stroke. 3: 182-187. PMID 18705897 DOI: 10.1111/J.1747-4949.2008.00197.X  0.457
2008 Nagel S, Papadakis M, Hoyte L, Buchan AM. Therapeutic hypothermia in experimental models of focal and global cerebral ischemia and intracerebral hemorrhage Expert Review of Neurotherapeutics. 8: 1255-1268. PMID 18671669 DOI: 10.1586/14737175.8.8.1255  0.486
2008 Kent DM, Buchan AM, Hill MD. The gender effect in stroke thrombolysis: Of CASES, controls, and treatment-effect modification Neurology. 71: 1080-1083. PMID 18495951 DOI: 10.1212/01.wnl.0000316191.84334.bd  0.406
2008 Muangpaisan W, Hinkle JL, Westwood M, Kennedy J, Buchan AM. Stroke in the very old: Clinical presentations and outcomes Age and Ageing. 37: 473-475. PMID 18448466 DOI: 10.1093/Ageing/Afn210  0.465
2008 Papadakis M, Nagel S, Buchan AM. Development and efficacy of NXY-059 for the treatment of acute ischemic stroke Future Neurology. 3: 229-240. DOI: 10.2217/14796708.3.3.229  0.502
2007 Kennedy J, Buchan AM. Moving forward with intra-arterial and intravenous stroke treatment International Journal of Stroke. 2: 45-46. PMID 18705987 DOI: 10.1111/J.1747-4949.2007.00084.X  0.478
2007 Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial Lancet Neurology. 6: 961-969. PMID 17931979 DOI: 10.1016/S1474-4422(07)70250-8  0.475
2007 Buchan AM, Hill MD. Is alteplase safe and effective in routine clinical practice for patients with ischemic stroke? Nature Clinical Practice. Cardiovascular Medicine. 4: 356-7. PMID 17519912 DOI: 10.1038/ncpcardio0912  0.403
2007 Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke Neurology. 68: 1020-1024. PMID 17389306 DOI: 10.1212/01.Wnl.0000257817.29883.48  0.468
2007 Buchan AM, Kennedy J. Strategies for therapy in acute ischemic stroke Nature Clinical Practice Neurology. 3: 2-3. PMID 17205064 DOI: 10.1038/Ncpneuro0393  0.516
2007 Sun HS, Feng ZP, Barber PA, Buchan AM, French RJ. Kir6.2-containing ATP-sensitive potassium channels protect cortical neurons from ischemic/anoxic injury in vitro and in vivo. Neuroscience. 144: 1509-15. PMID 17175112 DOI: 10.1016/J.Neuroscience.2006.10.043  0.373
2007 Dzialowski I, Pexman JHW, Barber PA, Demchuk AM, Buchan AM, Hill MD. Asymptomatic hemorrhage after thrombolysis may not be benign: Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry Stroke. 38: 75-79. PMID 17122437 DOI: 10.1161/01.Str.0000251644.76546.62  0.463
2007 Buchan AM, Hill MD. Is alteplase safe and effective in routine clinical practice for patients with ischemic stroke? Commentary Nature Clinical Practice Cardiovascular Medicine. 4: 356-357. DOI: 10.1038/Ncpcardio0912  0.5
2007 Ning MM, Montaner J, Wang X, Lee SR, Tsuji K, Tejima E, Buchan AM, Lo EH. Matrix metalloproteinases and tissue plasminogen activator reperfusion therapy for stroke Handbook of Neurochemistry and Molecular Neurobiology: Acute Ischemic Injury and Repair in the Nervous System. 269-286. DOI: 10.1007/978-0-387-30383-3_15  0.323
2006 Papadakis M, Buchan AM. Translational vehicles for neuroprotection Biochemical Society Transactions. 34: 1318-1322. PMID 17073811 DOI: 10.1042/Bst0341318  0.426
2006 Hoyte LC, Papadakis M, Barber PA, Buchan AM. Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning Brain Research. 1121: 231-237. PMID 17010948 DOI: 10.1016/J.Brainres.2006.08.107  0.407
2006 Muir KW, Buchan A, von Kummer R, Rother J, Baron JC. Imaging of acute stroke Lancet Neurology. 5: 755-768. PMID 16914404 DOI: 10.1016/S1474-4422(06)70545-2  0.405
2006 Weir NU, Pexman JHW, Hill MD, Buchan AM. How well does ASPECTS predict the outcome of acute stroke treated with IV tPA? Neurology. 67: 516-518. PMID 16894120 DOI: 10.1212/01.Wnl.0000228221.44334.73  0.472
2006 Hill MD, Kent DM, Hinchey J, Rowley H, Buchan AM, Wechsler LR, Higashida RT, Fischbein NJ, Dillon WP, Gent M, Firszt CM, Schulz GA, Furlan AJ. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke; a Journal of Cerebral Circulation. 37: 2322-5. PMID 16888269 DOI: 10.1161/01.Str.0000237060.21472.47  0.425
2006 Papadakis M, Buchan AM. NXY-059: Brain or vessel protection Stroke. 37: 2189-2190. PMID 16809574 DOI: 10.1161/01.Str.0000230598.31774.7A  0.497
2006 Pettersen JA, Pexman JHW, Barber PA, Demchuk AM, Buchan AM, Hill MD. Insular cortical ischaemia does not independently predict acute hypertension or hyperglycaemia within 3 h of onset Journal of Neurology, Neurosurgery and Psychiatry. 77: 885-887. PMID 16788017 DOI: 10.1136/Jnnp.2005.087494  0.375
2006 Tomanek AI, Coutts SB, Demchuk AM, Hudon ME, Morrish WE, Sevick RJ, Simon JE, Frayne R, Buchan AM, Hill MD. MR angiography compared to conventional selective angiography in acute stroke. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 33: 58-62. PMID 16583723 DOI: 10.1017/S0317167100004704  0.455
2006 Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. The Lancet. Neurology. 5: 323-31. PMID 16545749 DOI: 10.1016/S1474-4422(06)70408-2  0.519
2006 Zhao Z, Sun P, Chauhan N, Kaur J, Hill MD, Papadakis M, Buchan AM. Neuroprotection and neurogenesis: Modulation of cornus ammonis 1 neuronal survival after transient forebrain ischemia by prior fimbria-fornix deafferentation Neuroscience. 140: 219-226. PMID 16542783 DOI: 10.1016/J.Neuroscience.2006.02.011  0.404
2006 Ramasubbu R, Tobias R, Buchan AM, Bech-Hansen NT. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression Journal of Neuropsychiatry and Clinical Neurosciences. 18: 96-99. PMID 16525076 DOI: 10.1176/Jnp.18.1.96  0.345
2006 Chen LK, Buchan AM, Hwang SJ, Hinkle J. Cataract surgery after acute stroke: Maybe more than a coincidence [10] Stroke. 37: 766-767. PMID 16505344 DOI: 10.1161/01.Str.0000204088.04384.74  0.444
2006 Sylaja PN, Cote R, Buchan AM, Hill MD. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study Journal of Neurology, Neurosurgery and Psychiatry. 77: 826-829. PMID 16505004 DOI: 10.1136/Jnnp.2005.086595  0.483
2006 Kaur J, Zhao Z, Geransar RM, Papadakis M, Buchan AM. Prior deafferentation confers long term protection to CA1 against transient forebrain ischemia and sustains GluR2 expression Brain Research. 1075: 201-212. PMID 16480690 DOI: 10.1016/J.Brainres.2005.12.123  0.337
2006 Buchan AM. Acute stroke treatment: The end of the first decade Practical Neurology. 6: 338-340. DOI: 10.1136/Jnnp.2006.106427  0.469
2006 Weir NU, Demchuk AM, Buchan AM, Hill MD. Stroke prevention | İnmeden korunma Sendrom. 18: 26-30.  0.419
2005 Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, Tomanek A, Frayne R, Buchan AM. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1528-33. PMID 16227545 DOI: 10.1136/Jnnp.2004.059261  0.464
2005 Kennedy J, Quan H, Buchan AM, Ghali WA, Feasby TE. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients Stroke. 36: 2072-2076. PMID 16179564 DOI: 10.1161/01.Str.0000183623.28144.32  0.362
2005 Barber PA, Hoyte L, Kirk D, Foniok T, Buchan A, Tuor U. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T. Neuroscience Letters. 388: 54-59. PMID 16055267 DOI: 10.1016/J.Neulet.2005.06.067  0.383
2005 Coutts SB, Simon JE, Eliasziw M, Sohn CH, Hill MD, Barber PA, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott JN, Buchan AM, Demchuk AM. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging Annals of Neurology. 57: 848-854. PMID 15929051 DOI: 10.1002/Ana.20497  0.497
2005 Weir NU, Buchan AM. A study of the workload and effectiveness of a comprehensive acute stroke service Journal of Neurology, Neurosurgery and Psychiatry. 76: 863-865. PMID 15897513 DOI: 10.1136/Jnnp.2004.053462  0.495
2005 Simon JE, Bristow MS, Lu H, Lauzon ML, Brown RA, Manjón JV, Eliasziw M, Frayne R, Buchan AM, Demchuk AM, Mitchell JR. A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 1236-43. PMID 15889045 DOI: 10.1038/Sj.Jcbfm.9600130  0.448
2005 Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: Results of the Canadian Alteplase for Stroke Effectiveness Study Cmaj. 172: 1307-1312. PMID 15883405 DOI: 10.1503/Cmaj.1041561  0.534
2005 Sivakumar C, Palumbo V, Hill MD, Buchan AM, Bravata DM, Rosenbaum JR, Concato J, Brass LM, Kim N, Fried TR. Informed consent for thrombolytic therapy in acute ischemic stroke [3] (multiple letters) Stroke. 36: 528-529. PMID 15738575 DOI: 10.1161/01.Str.0000154854.92922.03  0.503
2005 Boulanger JM, Coutts SB, Hill MD, Demchuk AM, Buchan AM, Purroy F, Montaner J, Delgado P, Álvarez-Sabín J. Use of magnetic resonance imaging in predicting further vascular events among patients with transient ischemic attacks [2] (multiple letters) Stroke. 36: 526-528. PMID 15738574 DOI: 10.1161/01.Str.0000154859.25903.75  0.502
2005 Weir NU, Demchuk AM, Buchan AM, Hill MD. Stroke prevention: MATCHing therapy to the patient with TIA Postgraduate Medicine. 117: 26-30. PMID 15672888 DOI: 10.3810/Pgm.2005.01.1566  0.504
2005 Kaur J, Zhao Z, Geransar RM, Sun P, Buchan AM. Glutamate receptor subunit 2 (GluR2) expression mediates protection conferred to CA1 neurons from ischemic damage by prior fimbria-fornix deafferentation Journal of Cerebral Blood Flow & Metabolism. 25: S456-S456. DOI: 10.1038/Sj.Jcbfm.9591524.0456  0.317
2005 Wang R, Zhao Z, Rushforth D, Foniok T, Wamsteeker JI, Buchan A, Tomanek B, Tuor UI. Transient increases in blood pressure affect sensory-motor activation following stroke using functional MR imaging in the rat Journal of Cerebral Blood Flow & Metabolism. 25: S402-S402. DOI: 10.1038/Sj.Jcbfm.9591524.0402  0.388
2005 Hoyte LC, Buchan AM. Improved regional cerebral blood flow mediates tolerance afforded by ischemic preconditioning Journal of Cerebral Blood Flow & Metabolism. 25: S298-S298. DOI: 10.1038/Sj.Jcbfm.9591524.0298  0.375
2005 Zhao Z, Kaur J, Sun P, Hoyte L, Geransar R, Buchan A. Hypothermia following cerebral ischemia provides neuroprotection but is not beneficial toward neurogenesis Journal of Cerebral Blood Flow & Metabolism. 25: S225-S225. DOI: 10.1038/Sj.Jcbfm.9591524.0225  0.403
2004 Simon JE, Czechowsky DK, Hill MD, Harris AD, Buchan AM, Frayne R. Fluid-attenuated inversion recovery preparation: not an improvement over conventional diffusion-weighted imaging at 3T in acute ischemic stroke. Ajnr. American Journal of Neuroradiology. 25: 1653-8. PMID 15569726  0.305
2004 Coutts SB, Lev MH, Eliasziw M, Roccatagliata L, Hill MD, Schwamm LH, Pexman JH, Koroshetz WJ, Hudon ME, Buchan AM, Gonzalez RG, Demchuk AM. ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke; a Journal of Cerebral Circulation. 35: 2472-6. PMID 15486327 DOI: 10.1161/01.Str.0000145330.14928.2A  0.405
2004 Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke Stroke. 35: 2726-2730. PMID 15459442 DOI: 10.1161/01.Str.0000143219.16695.Af  0.477
2004 Barber PA, Demchuk AM, Hill MD, Pexman JH, Hudon ME, Frayne R, Buchan AM. The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1426-30. PMID 15377690 DOI: 10.1136/Jnnp.2003.029389  0.324
2004 Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator? Journal of Cerebral Blood Flow and Metabolism. 24: 945-963. PMID 15356416 DOI: 10.1097/01.Wcb.0000137868.50767.E8  0.357
2004 Barber PA, Foniok T, Kirk D, Buchan AM, Laurent S, Boutry S, Muller RN, Hoyte L, Tomanek B, Tuor UI. MR molecular imaging of early endothelial activation in focal ischemia Annals of Neurology. 56: 116-120. PMID 15236408 DOI: 10.1002/Ana.20162  0.346
2004 Barber PA, Hoyte L, Colbourne F, Buchan AM. Temperature-regulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes. Stroke; a Journal of Cerebral Circulation. 35: 1720-5. PMID 15155973 DOI: 10.1161/01.Str.0000129653.22241.D7  0.394
2004 Coutts SB, Demchuk AM, Barber PA, Hu WY, Simon JE, Buchan AM, Hill MD. Interobserver variation of ASPECTS in real time Stroke; a Journal of Cerebral Circulation. 35: e103-105. PMID 15073381 DOI: 10.1161/01.Str.0000127082.19473.45  0.444
2004 Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJ. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 170: 1105-9. PMID 15051694 DOI: 10.1503/Cmaj.1030460  0.492
2004 Pexman JHW, Hill MD, Buchan AM, Demchuk AM, Barber PA, Simon JE, Coutts SB, Saur D, Röther J, Kucinski T. Hyperacute Stroke: Experience Essential When Reading Unenhanced CT Scans American Journal of Neuroradiology. 25: 516-518. PMID 15037484  0.316
2004 Hoyte L, Barber PA, Buchan AM, Hill MD. The rise and fall of NMDA antagonists for ischemic stroke Current Molecular Medicine. 4: 131-136. PMID 15032709 DOI: 10.2174/1566524043479248  0.412
2004 Simon JE, Sandler DL, Pexman JHW, Hill MD, Buchan AM. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience Age and Ageing. 33: 143-149. PMID 14960429 DOI: 10.1093/Ageing/Afh031  0.464
2004 Di Legge S, Beletsky V, Jain V, Hachinski V, Simon JE, Morgan SC, Pexman JHW, Hill MD, Buchan AM. CT assessment of conjugate eye deviation in acute stroke [1] (multiple letters) Neurology. 62: 523. PMID 14872055 DOI: 10.1212/WNL.62.3.523  0.307
2004 Kennedy J, Buchan AM. Acute Neurovascular Syndromes: Hurry Up, Please, It's Time Stroke. 35: 360-362. PMID 14757879 DOI: 10.1161/01.Str.0000115260.19243.64  0.513
2004 Coutts SB, Barber PA, Demchuk AM, Hill MD, Pexman JHW, Hudon ME, Buchan AM. Mild Neurological Symptoms Despite Middle Cerebral Artery Occlusion Stroke. 35: 469-471. PMID 14726548 DOI: 10.1161/01.Str.0000110985.01773.7F  0.532
2004 Kennedy J, Ma C, Buchan AM. Organization of regional and local stroke resources: Methods to expedite acute management of stroke Current Neurology and Neuroscience Reports. 4: 13-18. PMID 14683622 DOI: 10.1007/S11910-004-0005-9  0.504
2003 Coutts SB, Hill MD, Demchuk AM, Barber PA, Pexman JHW, Buchan AM. ASPECTS reading requires training and experience Stroke; a Journal of Cerebral Circulation. 34: e179; author reply e. PMID 12970512 DOI: 10.1161/01.Str.0000092221.81498.91  0.336
2003 Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke; a Journal of Cerebral Circulation. 34: 1925-31. PMID 12843342 DOI: 10.1161/01.Str.0000082483.37127.D0  0.511
2003 Coutts SB, Simon JE, Tomanek AI, Barber PA, Chan J, Hudon ME, Mitchell JR, Frayne R, Eliasziw M, Buchan AM, Demchuk AM. Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke; a Journal of Cerebral Circulation. 34: 1681-3. PMID 12805485 DOI: 10.1161/01.Str.0000078840.96473.20  0.369
2003 Barber PA, Demchuk AM, Hirt L, Buchan AM. Biochemistry of ischemic stroke Advances in Neurology. 92: 151-164. PMID 12760178  0.435
2003 Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, Green TL, Kenney C, Cole-Haskayne A, Buchan AM. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke Neurology. 60: 1525-1527. PMID 12743244 DOI: 10.1212/01.Wnl.0000058840.66596.1A  0.452
2003 Watson TW, Simon JE, Buchan AM. Stroke care: the way forward. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 411-2. PMID 12640048 DOI: 10.1136/Jnnp.74.4.411  0.522
2003 Colbourne F, Grooms SY, Zukin RS, Buchan AM, Bennett MV. Hypothermia rescues hippocampal CA1 neurons and attenuates down-regulation of the AMPA receptor GluR2 subunit after forebrain ischemia. Proceedings of the National Academy of Sciences of the United States of America. 100: 2906-10. PMID 12606709 DOI: 10.1073/Pnas.2628027100  0.313
2003 Kennedy J, Buchan AM. Ever decreasing circles: Advances in antiplatelet therapy and anticoagulation Stroke. 34: 348-350. PMID 12574532 DOI: 10.1161/01.Str.0000054264.39521.56  0.498
2003 Chauhan N, Zhao Z, Barber PA, Buchan AM. Lessons in experimental ischemia for clinical stroke medicine Current Opinion in Neurology. 16: 65-71. PMID 12544859 DOI: 10.1097/01.Wco.0000053588.70044.5A  0.479
2003 Simon JE, Morgan SC, Pexman JH, Hill MD, Buchan AM. CT assessment of conjugate eye deviation in acute stroke. Neurology. 60: 135-7. PMID 12525738 DOI: 10.1212/01.Wnl.0000042086.98735.75  0.416
2003 KENNEDY J, ELIASZIW M, HILL M, BUCHAN A. The fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER) trial Seminars in Cerebrovascular Diseases and Stroke. 3: 25-30. DOI: 10.1053/Scds.2003.00009  0.491
2002 Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR, Hamilton SA, Hanson SK, Grotta JC, Morgenstern L, Krieger D, Villar C, Chiu D, Wein T, ... ... Buchan AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The multicenter rt-PA acute stroke survey Circulation. 105: 1679-1685. PMID 11940547 DOI: 10.1161/01.CIR.0000012747.53592.6A  0.435
2002 Hill MD, Barber PA, Demchuk AM, Newcommon NJ, Cole-Haskayne A, Ryckborst K, Sopher L, Button A, Hu W, Hudon ME, Morrish W, Frayne R, Sevick RJ, Buchan AM. Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke. Stroke; a Journal of Cerebral Circulation. 33: 279-82. PMID 11779923 DOI: 10.1161/Hs0102.101900  0.497
2001 Hill MD, Gubitz GJ, Phillips SJ, Buchan AM. Thrombolytic therapy for acute ischemic stroke - The CAEP Position Statement: another perspective. Cjem. 3: 180-2. PMID 17610780 DOI: 10.1017/S1481803500005509  0.461
2001 Kennedy J, Buchan AM, Barnett HJ. Thrombolysis must be considered after stroke. Bmj (Clinical Research Ed.). 323: 937. PMID 11668151 DOI: 10.1136/Bmj.323.7318.937/B  0.499
2001 Pexman JHW, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, Hu WY, Buchan AM. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke American Journal of Neuroradiology. 22: 1534-1542. PMID 11559501  0.321
2001 Hill MD, Buchan AM. Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES) Canadian Journal of Neurological Sciences. 28: 232-238. PMID 11513342 DOI: 10.1017/S0317167100001384  0.506
2001 Zhao Z, Cheng M, Maples KR, Ma JY, Buchan AM. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat Brain Research. 909: 46-50. PMID 11478919 DOI: 10.1016/S0006-8993(01)02618-X  0.332
2001 Buchan A. Aspects of stroke imaging. Canadian Journal of Neurological Sciences. 28: 99-100. PMID 11383947 DOI: 10.1017/S0317167100052744  0.467
2001 Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 56: 1015-20. PMID 11320171 DOI: 10.1212/WNL.56.8.1015  0.374
2001 Barber PA, Auer RN, Buchan AM, Sutherland GR. Understanding and managing ischemic stroke. Canadian Journal of Physiology and Pharmacology. 79: 283-96. PMID 11294605 DOI: 10.1139/Y00-125  0.477
2001 Buchan AM, Warren D, Burnstein R, Kondziolka D. Transplantation of cultured human neuronal cells for patients with stroke [2] Neurology. 56: 821-822. PMID 11274333 DOI: 10.1212/Wnl.56.6.820-A  0.313
2001 Hill MD, Barber PA, Demchuk AM, Sevick RJ, Frayne R, Buchan AM. Symptomatic hemorrhage after alteplase therapy not due to silent ischemia. Bmc Neurology. 1: 1. PMID 11208259 DOI: 10.1186/1471-2377-1-1  0.543
2001 Li H, Klein G, Sun P, Buchan AM. Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia Brain Research. 888: 263-266. PMID 11150483 DOI: 10.1016/S0006-8993(00)03077-8  0.327
2001 Barber PA, Demchuk AM, Hudon ME, Warwick Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia Stroke. 32: 84-88. PMID 11136919 DOI: 10.1161/01.Str.32.1.84  0.475
2001 Hill MD, Newcommon N, Barber PA, Demchuk AM, Buchan AM. Intra-arterial therapy following intravenous alteplase for severe ischemic stroke Stroke. 32: 374-374. DOI: 10.1161/01.Str.32.Suppl_1.374  0.474
2001 Barber PA, Zhang J, Demchuk AM, Hill MD, Cole-Haskayne A, Newcommon N, Virji H, Buchan AM. Why stroke patients don't receive t-PA? An analysis of patient eligibility: Implications for improving clinical impact by increasing future treatment numbers Stroke. 32: 372-372. DOI: 10.1161/01.Str.32.Suppl_1.372-D  0.514
2001 Barber PA, Demchuk AM, Hudon ME, Pexman W, Hill MD, Buchan AM. The hyperdense sylvian fissure MCA "dot" sign: a marker of acute CT ischemia Stroke. 32: 346-346. DOI: 10.1161/01.Str.32.Suppl_1.346-B  0.454
2001 Barber PA, Demchuk AM, Hill MD, Pexman W, Hudon ME, Tomanek A, Beaupre D, Frayne R, Buchan AM. A comparison of CT versus MR imaging in acute stroke using ASPECTS: Will the “new” replace the “old” as the preferred imaging modality? Stroke. 32: 325-325. DOI: 10.1161/01.Str.32.Suppl_1.325  0.46
2001 Hill MD, Buchan AM. The Canadian Activase for Stroke Effectiveness Study (CASES): Interim results Stroke. 32: 323-323. DOI: 10.1161/01.Str.32.Suppl_1.323-A  0.532
2001 Hill, Barber PA, Demchuk AM, Pexman W, Buchan AM, Investigators C. Baseline ASPECT Scores predict extent of stroke: Interim CT Analysis of CASES Stroke. 32: 319-320. DOI: 10.1161/01.Str.32.Suppl_1.319-D  0.371
2001 Warren DT, Buchan AM. Cerebral Ischemia: Molecular and Cellular Pathophysiology. 1st Edition. 1999. Edited by Wolfgang Walz. Published by Humana Press Inc. 278 pages. C$181.25 approx. Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 28: 380-380. DOI: 10.1017/S0317167100019260  0.323
2000 Buchan AM, Feasby TE. Stroke thrombolysis: Is tissue plasminogen activator a defibrillator for the brain? Cmaj. 162: 47-48. PMID 11216198  0.348
2000 Colbourne F, Corbett D, Zhao Z, Yang J, Buchan AM. Prolonged but delayed postischemic hypothermia: a long-term outcome study in the rat middle cerebral artery occlusion model. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 1702-8. PMID 11129786 DOI: 10.1097/00004647-200012000-00009  0.38
2000 Barber PA, Hill MD, Demchuk AM, Buchan AM. Doubts, fears and misconceptions. What is the future of thrombolysis in acute stroke? Canadian Journal of Neurological Sciences. 27: 283-287. PMID 11097516 DOI: 10.1017/S0317167100001001  0.513
2000 Small DL, Buchan AM. Animal models. British Medical Bulletin. 56: 307-17. PMID 11092082 DOI: 10.1258/0007142001903238  0.412
2000 MacManus JP, Buchan AM. Apoptosis after experimental stroke: Fact or fashion? Journal of Neurotrauma. 17: 899-914. PMID 11063056 DOI: 10.1089/Neu.2000.17.899  0.43
2000 Nawashiro H, Fukui S, Barber PA, Demchuk AM, Buchan AM. Intra-arterial thrombolysis for hyperacute stroke [5] (multiple letters) Lancet. 356: 1111-1112. PMID 11009167  0.388
2000 Li H, Klein G, Sun P, Buchan AM. CoQ10 fails to protect brain against focal and global ischemia in rats Brain Research. 877: 7-11. PMID 10980237 DOI: 10.1016/S0006-8993(00)02609-3  0.411
2000 Hill MD, Barber PA, Demchuk AM, Buchan AM, Bath P, Bath F, Rashid P, Weaver C. Acute ischaemic stroke (multiple letters) British Medical Journal. 321: 299-300. PMID 10979695  0.411
2000 Chodirker WB, Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Reactions to alteplase in patients with acute thrombotic stroke [2] (multiple letters) Cmaj. 163: 387-389. PMID 10976251  0.366
2000 Buchan AM. Can pure oxygen prevent stroke damage? Critical Care Medicine. 28: 3101. PMID 10966313 DOI: 10.1097/00003246-200008000-00081  0.465
2000 Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy Lancet. 355: 1670-1674. PMID 10905241 DOI: 10.1016/S0140-6736(00)02237-6  0.461
2000 Barnett HJ, Buchan AM. The imperative to develop dedicated stroke centers. Jama. 283: 3125-6. PMID 10865309 DOI: 10.1001/Jama.283.23.3125  0.525
2000 Hill MD, Barber PA, Demchuk AM, Sevick RJ, Newcommon NJ, Green T, Buchan AM. Building a 'brain attack' team to administer thrombolytic therapy for acute ischemic stroke Cmaj. 162: 1589-1593. PMID 10862236  0.435
2000 Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke Cmaj. 162: 1281-1284. PMID 10813008  0.367
2000 Demchuk AM, Buchan AM. Predictors of stroke outcome Neurologic Clinics. 18: 455-473. PMID 10757836 DOI: 10.1016/S0733-8619(05)70202-4  0.436
2000 Buchan AM, Barber PA, Newcommon N, Karbalai HG, Demchuk AM, Hoyte KM, Klein GM, Feasby TE. Effectiveness of t-PA in acute ischemic stroke: Outcome relates to appropriateness Neurology. 54: 679-684. PMID 10680803 DOI: 10.1212/Wnl.54.3.679  0.508
2000 Buchan AM, Li H, Blackburn B. Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-κB activation Neuroreport. 11: 427-430. PMID 10674500 DOI: 10.1097/00001756-200002070-00041  0.386
2000 Li H, Colbourne F, Sun P, Zhao Z, Buchan AM, Iadecola C. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke; a Journal of Cerebral Circulation. 31: 176-82. PMID 10625735 DOI: 10.1161/01.Str.31.1.176  0.39
2000 Barber PA, Demchuk AM, Buchan AM. Intra-arterial thrombolysis for hyperacute stroke The Lancet. 356: 1112. DOI: 10.1016/S0140-6736(05)74554-2  0.489
2000 Verbeek R, Buchan AM, Feasby TE. Treating stroke [1] (multiple letters) Cmaj. 162: 1273-1274.  0.421
2000 Hill MD, Barber PA, Demchuk AM, Buchan AM. Time is brain: Post-marketing experience with alteplase (tPA) for acute ischemic stroke Today's Therapeutic Trends. 18: 285-304.  0.368
1999 Small DL, Morley P, Buchan AM. Biology of ischemic cerebral cell death. Progress in Cardiovascular Diseases. 42: 185-207. PMID 10598920 DOI: 10.1016/S0033-0620(99)70002-2  0.487
1999 Huang ZG, Xue D, Preston E, Karbalai H, Buchan AM. Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 26: 298-304. PMID 10563216 DOI: 10.1017/S0317167100000421  0.328
1999 Scott JN, Buchan AM, Sevick RJ. Correlation of neurologic dysfunction with CT findings in early acute stroke. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 26: 182-9. PMID 10451740 DOI: 10.1017/S0317167100000226  0.471
1999 Colbourne F, Li H, Buchan AM. Indefatigable CA1 sector neuroprotection with mild hypothermia induced 6 hours after severe forebrain ischemia in rats. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 742-9. PMID 10413028 DOI: 10.1097/00004647-199907000-00003  0.339
1999 Klein GM, Li H, Sun P, Buchan AM. Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia. Neurology. 52: 1381-4. PMID 10227621 DOI: 10.1212/Wnl.52.7.1381  0.452
1999 Colbourne F, Li H, Buchan AM, Clemens JA. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke; a Journal of Cerebral Circulation. 30: 662-8. PMID 10066868 DOI: 10.1161/01.Str.30.3.662  0.332
1999 Demchuk AM, Morgenstern LB, Krieger DW, Linda Chi T, Hu W, Wein TH, Hardy RJ, Grotta JC, Buchan AM. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 30: 34-9. PMID 9880385 DOI: 10.1161/01.Str.30.1.34  0.489
1998 Norris JW, Buchan A, Cote R, Hachinski V, Phillips SJ, Shuaib A, Silver F, Simard D, Teal P. Canadian guidelines for intravenous thrombolytic treatment in acute stroke: A consensus statement of the canadian stroke consortium Canadian Journal of Neurological Sciences. 25: 257-259. PMID 9706731 DOI: 10.1017/S0317167100034120  0.494
1997 Hou ST, Tu Y, Buchan AM, Huang Z, Preston E, Rasquinha I, Robertson GS, MacManus JP. Increases in DNA lesions and the DNA damage indicator Gadd45 following transient cerebral ischemia. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 75: 383-92. PMID 9493961 DOI: 10.1139/O97-059  0.324
1997 Small DL, Poulter MO, Buchan AM, Morley P. Alteration in NMDA receptor subunit mRNA expression in vulnerable and resistant regions of in vitro ischemic rat hippocampal slices. Neuroscience Letters. 232: 87-90. PMID 9302093 DOI: 10.1016/S0304-3940(97)00592-2  0.308
1997 Lingenhöhl K, Small DL, Monette R, Buchan AM, Morley P, Allegrini PR, Fröst LW, Sauer D, Schmutz M, Knöpfel T. Exploration of P-type Ca2+ channels as drug targets for the treatment of epilepsy or ischemic stroke. Neuropharmacology. 36: 107-13. PMID 9144647 DOI: 10.1016/S0028-3908(96)00158-X  0.401
1997 Kozlowski P, Buchan AM, Tuor UI, Xue D, Huang Z, Chaundy KE, Saunders JK. Effect of temperature in focal ischemia of rat brain studied by 31P and 1H spectroscopic imaging. Magnetic Resonance in Medicine. 37: 346-354. PMID 9055223 DOI: 10.1002/Mrm.1910370307  0.363
1997 Small DL, Buchan AM. NMDA antagonists: their role in neuroprotection. International Review of Neurobiology. 40: 137-71. PMID 8989620 DOI: 10.1016/S0074-7742(08)60719-9  0.334
1996 Small DL, Buchan AM. Mechanisms of cerebral ischemia: intracellular cascades and therapeutic interventions. Journal of Cardiothoracic and Vascular Anesthesia. 10: 139-46. PMID 8634379 DOI: 10.1016/S1053-0770(96)80189-3  0.369
1994 Takizawa S, Hogan MJ, Buchan AM, Hakim AM. In vivo binding of [3H]nimodipine in rat brain after transient forebrain ischemia Journal of Cerebral Blood Flow and Metabolism. 14: 397-405. PMID 8163582 DOI: 10.1038/Jcbfm.1994.51  0.324
1994 MacManus JP, Buchan AM, Hill IE, Rasquinha I, Preston E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neuroscience Letters. 164: 89-92. PMID 8152622 DOI: 10.1016/0304-3940(93)90864-H  0.361
1994 Buchan AM, Gertler SZ, Li H, Xue D, Huang ZG, Chaundy KE, Barnes K, Lesiuk HJ. A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 903-10. PMID 7929655 DOI: 10.1038/Jcbfm.1994.121  0.378
1994 Buchan AM, Gertler SZ, Huang ZG, Li H, Chaundy KE, Xue D. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase. Neuroscience. 61: 1-11. PMID 7526264 DOI: 10.1016/0306-4522(94)90054-X  0.365
1994 Xue D, Huang ZG, Barnes K, Lesiuk HJ, Smith KE, Buchan AM. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 251-61. PMID 7509339 DOI: 10.1038/Jcbfm.1994.32  0.351
1993 Pulsinelli W, Sarokin A, Buchan A. Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia. Progress in Brain Research. 96: 125-35. PMID 8392737 DOI: 10.1016/S0079-6123(08)63262-8  0.39
1993 Buchan AM, Lesiuk H, Barnes KA, Li H, Huang ZG, Smith KE, Xue D. AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists? Stroke; a Journal of Cerebral Circulation. 24: I148-52. PMID 7504338  0.309
1993 Stenerson PE, Buchan AM. Recent advances in the treatment of acute ischemic stroke Current Opinion in Orthopaedics. 4: 23-28. DOI: 10.1097/00001433-199310000-00006  0.415
1992 Buchan AM, Li H, Cho S, Pulsinelli WA. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neuroscience Letters. 132: 255-8. PMID 1664505 DOI: 10.1016/0304-3940(91)90314-J  0.317
1992 Xue D, Slivka A, Buchan AM. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Stroke. 23: 894-9. PMID 1595111 DOI: 10.1161/01.Str.23.6.894  0.378
1992 Buchan AM, Xue D, Slivka A. A new model of temporary focal neocortical ischemia in the rat. Stroke. 23: 273-9. PMID 1561658 DOI: 10.1161/01.Str.23.2.273  0.309
1992 Xue D, Huang ZG, Smith KE, Buchan AM. Immediate or delayed mild hypothermia prevents focal cerebral infarction. Brain Research. 587: 66-72. PMID 1525650 DOI: 10.1016/0006-8993(92)91428-H  0.37
1992 Buchan AM, Slivka A, Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Research. 574: 171-7. PMID 1386274 DOI: 10.1016/0006-8993(92)90814-P  0.411
1992 Buchan A. Advances in Cerebral Ischemia: Experimental Approaches Neurologic Clinics. 10: 49-61. DOI: 10.1016/S0733-8619(18)30233-0  0.448
1991 Buchan AM, Xue D, Huang ZG, Smith KH, Lesiuk H. Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia. Neuroreport. 2: 473-6. PMID 1655110 DOI: 10.1097/00001756-199108000-00016  0.39
1991 Buchan A, Li H, Pulsinelli WA. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. The Journal of Neuroscience. 11: 1049-1056. DOI: 10.1523/Jneurosci.11-04-01049.1991  0.319
1990 Buchan AM, Pulsinelli WA. Septo-hippocampal deafferentation protects CA1 neurons against ischemic injury. Brain Research. 512: 7-14. PMID 2337809 DOI: 10.1016/0006-8993(90)91163-B  0.338
1990 Buchan A, Pulsinelli W. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia The Journal of Neuroscience. 10: 311-316. DOI: 10.1523/Jneurosci.10-01-00311.1990  0.337
1988 Buchan A, Gates P, Pelz D, Barnett HJ. Intraluminal thrombus in the cerebral circulation. Implications for surgical management. Stroke. 19: 681-7. PMID 3376159 DOI: 10.1161/01.Str.19.6.681  0.371
1986 Pelz DM, Buchan A, Fox AJ, Barnett HJ, Vinuela F. Intraluminal thrombus of the internal carotid arteries: angiographic demonstration of resolution with anticoagulant therapy alone. Radiology. 160: 369-73. PMID 3726115 DOI: 10.1148/Radiology.160.2.3726115  0.32
1982 Buchan A. Fundamentals of neurology Journal of the Neurological Sciences. 56: 132. DOI: 10.1016/0022-510X(82)90072-7  0.347
Show low-probability matches.